Skip to main content

Table 3 Measures table and timing

From: DEFENS - Drug Exposure Feedback and Education for Nurses’ Safety: study protocol for a randomized controlled trial

Concept

Measure

Description

When collected

Outcome

Revised Drug Handling Questionnaire

Five items, 0 to 5 (never to always) use selected PPE items

Baseline

Primary endpoint

Mediator: Knowledge

Knowledge questionnaire

Twelve items, multiple choice, true/false about 2004 NIOSH alert and recommendations

Baseline

After viewing module

Primary endpoint

Mediator: Perceived Risk

Three items from Geer’s dermal exposure survey

Three items, score 1 to 4 (strongly disagree -strongly agree) about health risks from exposure

Baseline

Primary endpoint

Personal Factor

Experience

Number of years in nursing, oncology nursing, and in current position

Baseline

Personal Factor

Highest education degree completed

Diploma, Associates’ Bachelors, Masters, or Doctorate

Baseline

Personal Factor

Completed certifications

ONS Chemotherapy certification, OCN, AOCN

Baseline

Organizational Factor

Workload

Number of patients cared for on shift

Baseline

With a spill report

Primary endpoint

Organizational Factor

Revised PES-NWI

Six subscales, 23 items, score range 0 to 5 (strongly disagree - strongly agree) about presence of favorable work features

Baseline

Primary endpoint

Organizational Factor

Safety Organizing Scale

Nine items, score range 1 to 7 (not at all - to a very great extent) team performance of safety behaviors

Baseline

Primary endpoint

  1. AOCN: Advanced Oncology Certified Nurse; OCN: Oncology Certified Nurse; ONS: Oncology Nursing Society; PES-NWI: Practice Environment Scale of the Nursing Work Index.
  2. Note. Baseline assessment begins in Year 1 of the study; the Primary endpoint is assessed approximately 18 months later.